Prophylactic Application of Donor-derived TCM After Allogeneic HSCT

Clinical trial NCT02758223 · COMPLETED

Trial details

NCT number: NCT02758223
Sponsor: Wuerzburg University Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes

Start date: 2016-04-01
Primary completion: 2021-05-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.